These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2486186)

  • 1. Importance of evaporative water losses during standardized nebulized inhalation provocation tests.
    Cockcroft DW; Hurst TS; Gore BP
    Chest; 1989 Sep; 96(3):505-8. PubMed ID: 2486186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new method for measuring aerosol nebulizer output using radioactive tracers.
    Gatnash AA; Chandler ST; Connolly CK
    Eur Respir J; 1998 Aug; 12(2):467-71. PubMed ID: 9727803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in nebulizer aerosol output and weight output from the Mefar dosimeter: implications for multicentre studies.
    Chinn S; Arossa WA; Jarvis DL; Luczynska CM; Burney PG
    Eur Respir J; 1997 Feb; 10(2):452-6. PubMed ID: 9042648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased bronchial responsiveness to histamine associated with shortened inhalation time.
    Vázquez C; Rodríguez-Soriano J
    Pediatr Pulmonol; 1989; 6(2):99-102. PubMed ID: 2927976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration of aerosol output from the Mefar dosimeter: implications for epidemiological studies.
    Dennis JH; Avery AJ; Walters EH; Hendrick DJ
    Eur Respir J; 1992 Nov; 5(10):1279-82. PubMed ID: 1486976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physical properties of a jet-nebulizer and their relevance for the histamine provocation test.
    Sterk PJ; Plomp A; Crobach MJ; van de Vate JF; Quanjer PH
    Bull Eur Physiopathol Respir; 1983; 19(1):27-36. PubMed ID: 6850144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methacholine Challenge Testing: A Novel Method for Measuring PD
    Davis BE; Simonson SK; Blais CM; Cockcroft DW
    Chest; 2017 Dec; 152(6):1251-1257. PubMed ID: 28923758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchial challenge: a small reservoir for the Wright jet nebulizer.
    Madsen F; Nielsen NH; Frølund L; Svendsen UG; Weeke B
    Bull Eur Physiopathol Respir; 1987; 23(1):67-71. PubMed ID: 3593997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in nebulizer output and weight output from Mefar dosimeter: implications for multicentre studies.
    Ward RJ; Reid DW; Walters EH
    Eur Respir J; 1997 Oct; 10(10):2436-7. PubMed ID: 9387980
    [No Abstract]   [Full Text] [Related]  

  • 10. Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer.
    Blais CM; Cockcroft DW; Veilleux J; Boulay MÈ; Boulet LP; Gauvreau GM; Scime TX; Watson RM; O'Byrne PM; Davis BE
    J Aerosol Med Pulm Drug Deliv; 2018 Apr; 31(2):88-93. PubMed ID: 28813613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of driving pressure and nebulizer model on aerosol output during intermittent delivery with a dosimeter.
    Alkins SA; Hurwitz KM; Sierra A
    J Aerosol Med; 2002; 15(1):1-6. PubMed ID: 12006140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The salt output of a nebulizer--a comparison between two nebulizer types.
    Eklund L; Sundblad BM; Malmberg P; Larsson K
    Respir Med; 2000 Feb; 94(2):139-44. PubMed ID: 10714419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of nebulizer output over the years.
    Merkus PJ; van Essen-Zandvliet EE; Parlevliet E; Borsboom G; Sterk PJ; Kerrebijn KF; Quanjer PH
    Eur Respir J; 1992 Apr; 5(4):488-91. PubMed ID: 1563507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the provocative concentration of methacholine causing a 20% fall in FEV1 between the AeroEclipse II breath-actuated nebulizer and the wright nebulizer in adult subjects with asthma.
    El-Gammal AI; Killian KJ; Scime TX; Beaudin S; Schlatman A; Cockcroft DW; Gauvreau GM
    Ann Am Thorac Soc; 2015 Jul; 12(7):1039-43. PubMed ID: 25871542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenging the two-minute tidal breathing challenge test.
    Lexmond AJ; Hagedoorn P; Frijlink HW; de Boer AH
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):380-6. PubMed ID: 23509936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
    Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
    Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal duration of nebulized albuterol therapy.
    Malone RA; Hollie MC; Glynn-Barnhart A; Nelson HS
    Chest; 1993 Oct; 104(4):1114-8. PubMed ID: 8404177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro study to investigate the use of a breath-actuated, small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent.
    Mitchell JP; Nagel MW; Bates SL; Doyle CC
    Respir Care; 2003 Jan; 48(1):46-51. PubMed ID: 12556261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulizer output for methacholine challenges with the KoKo Digidoser.
    Khan YR; McDonough P; Cockcroft DW; David BE; Hendeles L
    J Allergy Clin Immunol; 2005 Oct; 116(4):924-6. PubMed ID: 16210072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.